1. |
van der Aalst CM, Ten Haaf K, de Koning HJ. Lung cancer screening: Latest developments and unanswered questions. Lancet Respir Med, 2016, 4(9): 749-761.
|
2. |
Heuvelmans MA, Walter JE, Peters RB, et al. Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study. Lung Cancer, 2017, 113: 45-50.
|
3. |
MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. Radiology, 2017, 284(1): 228-243.
|
4. |
张晓菊, 白莉, 金发光, 等. 肺结节诊治中国专家共识(2018年版). 中华结核和呼吸杂志, 2018, 41(10): 763-771.
|
5. |
Shimada Y, Saji H, Otani K, et al. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions. Lung Cancer, 2015, 88(2): 174-180.
|
6. |
Sato Y, Fujimoto D, Morimoto T, et al. Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacity. Respirology, 2017, 22(8): 1615-1621.
|
7. |
Chelala L, Hossain R, Kazerooni EA, et al. Lung-RADS version 1. 1: Challenges and a look ahead, from the AJR Special Series on Radiology Reporting and Data Systems. AJR Am J Roentgenol, 2021, 216(6): 1411-1422.
|
8. |
Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg, 1975, 70(4): 606-612.
|
9. |
Leventakos K, Peikert T, Midthun DE, et al. Management of multifocal lung cancer: Results of a survey. J Thorac Oncol, 2017, 12(9): 1398-1402.
|
10. |
Ettinger DS, Wood DE, Aggarwal C, et al. NCCN guidelines insights: Non-small cell lung cancer, version 1. 2020. J Natl Compr Canc Netw, 2019, 17(12): 1464-1472.
|
11. |
Galetta D, Solli P, Borri A, et al. Bilobectomy for lung cancer: Analysis of indications, postoperative results, and long-term outcomes. Ann Thorac Surg, 2012, 93(1): 251-257.
|
12. |
Yao F, Yang H, Zhao H. Single-stage bilateral pulmonary resections by video-assisted thoracic surgery for multiple small nodules. J Thorac Dis, 2016, 8(3): 469-475.
|
13. |
Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): A multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet, 2022, 399(10335): 1607-1617.
|
14. |
Suzuki K, Watanabe SI, Wakabayashi M, et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg, 2022, 163(1): 289-301.
|
15. |
Watanabe T, Tanahashi M, Suzuki E, et al. Surgical treatment for synchronous multiple primary lung cancer: Is it possible to achieve both curability and preservation of the pulmonary function? Thorac Cancer, 2021, 12(22): 2996-3004.
|
16. |
Ghosh S, Mehta AC, Abuquyyas S, et al. Primary lung neoplasms presenting as multiple synchronous lung nodules. Eur Respir Rev, 2020, 29(157): 190142.
|
17. |
魏星, 刘向阳. 同时性多原发肺腺癌31例临床分析与治疗体会. 中国医刊, 2017, 52(5): 86-90.
|
18. |
Shintani Y, Okami J, Ito H, et al. Clinical features and outcomes of patients with stage Ⅰ multiple primary lung cancers. Cancer Sci, 2021, 112(5): 1924-1935.
|
19. |
Chaft JE, Rimner A, Weder W, et al. Evolution of systemic therapy for stages Ⅰ-Ⅲ non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol, 2021, 18(9): 547-557.
|
20. |
Liu Y, Tang Y, Xue Z, et al. SUVmax ratio on PET/CT may differentiate between lung metastases and synchronous multiple primary lung cancer. Acad Radiol, 2020, 27(5): 618-623.
|
21. |
Dijkman BG, Schuurbiers OC, Vriens D, et al. The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours. Eur J Nucl Med Mol Imaging, 2010, 37(11): 2037-2047.
|
22. |
Wu HB, Wang L, Wang QS, et al. Adenocarcinoma with BAC features presented as the nonsolid nodule is prone to be false-negative on 18F-FDG PET/CT. Biomed Res Int, 2015, 2015: 243681.
|
23. |
Li M, Wan Y, Zhang L, et al. Synchronous multiple lung cancers presenting as multifocal pure ground glass nodules: Are whole-body positron emission tomography/computed tomography and brain enhanced magnetic resonance imaging necessary? Transl Lung Cancer Res, 2019, 8(5): 649-657.
|
24. |
Suh YJ, Lee HJ, Sung P, et al. A novel algorithm to differentiate between multiple primary lung cancers and intrapulmonary metastasis in multiple lung cancers with multiple pulmonary sites of involvement. J Thorac Oncol, 2020, 15(2): 203-215.
|
25. |
周丽娜, 吴宁, 赵世俊, 等. 基于高分辨率CT特征鉴别同时多原发肺腺癌与肺腺癌伴肺内转移. 中华肿瘤杂志, 2020, 42(6): 449-455.
|
26. |
Yotsukura M, Asamura H, Motoi N, et al. Long-term prognosis of patients with resected adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung. J Thorac Oncol, 2021, 16(8): 1312-1320.
|
27. |
Asmar R, Sonett JR, Singh G, et al. Use of oncogenic driver mutations in staging of multiple primary lung carcinomas: A single-center experience. J Thorac Oncol, 2017, 12(10): 1524-1535.
|
28. |
Yang Y, Yin W, He W, et al. Phenotype-genotype correlation in multiple primary lung cancer patients in China. Sci Rep, 2016, 6: 36177.
|
29. |
Takahashi Y, Shien K, Tomida S, et al. Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis. Cancer Sci, 2018, 109(11): 3634-3642.
|
30. |
Goodwin D, Rathi V, Conron M, et al. Genomic and clinical significance of multiple primary lung cancers as determined by next-generation sequencing. J Thorac Oncol, 2021, 16(7): 1166-1175.
|
31. |
Eberhardt WE, Mitchell A, Crowley J, et al. The IASLC lung cancer staging project: Proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol, 2015, 10(11): 1515-1522.
|
32. |
Ishikawa Y, Nakayama H, Ito H, et al. Surgical treatment for synchronous primary lung adenocarcinomas. Ann Thorac Surg, 2014, 98(6): 1983-1988.
|
33. |
郭海法, 毛锋, 张辉, 等. 同时性多原发肺癌的预后及生存相关因素研究. 中国肺癌杂志, 2017, 20(1): 21-27.
|